Small molecule shows early-stage promise for

<p>A breakthrough study led by experts at Cincinnati Children&#39;s--published May 2, 2024, in <em>Cell--</em>appears to overcome difficulties that have long frustrated previous attempts to reverse a form of nerve damage that robs people with MS of motor control and gradually blunts cognitive functions for many people as they age.&nbsp;</p>

Related Keywords

United Kingdom ,Cincinnati ,Ohio ,United States ,University Of Cincinnati ,Singapore ,India ,Germany ,Australia ,Sichuan ,Gansu ,China ,Adam Dourson ,Arman Bayat ,Liguo Zhang ,Dazhuan Eric Xin ,Chuntao Zhao ,Xuezhao Liu ,Q Richard Lu ,Mei Xin ,Xiaowen Zhong ,Jason Tchieu ,Reva Nicholson ,William Seibel ,Bingfang Yan ,Michael Jankowski ,Division Of Pharmaceutical Sciences ,National Multiple Sclerosis Society ,Method Of Research ,National Key Rd Program Of China ,National Institutes Of Health ,China Second University Hospital ,Cincinnati Children ,West China Second University Hospital ,Pharmaceutical Sciences ,National Institutes ,National Key Rd Program ,